Details for New Drug Application (NDA): 084931
NDA 084931 describes METHAMPHETAMINE HYDROCHLORIDE, which is a drug marketed by Able, Dr Reddys Labs Sa, Hikma, Rexar, and Teva, and is included in five NDAs. It is available from three suppliers. Additional details are available on the METHAMPHETAMINE HYDROCHLORIDE profile page.
The generic ingredient in METHAMPHETAMINE HYDROCHLORIDE is methamphetamine hydrochloride. There is one drug master file entry for this compound. Three suppliers are listed for this compound. Additional details are available on the methamphetamine hydrochloride profile page.
The generic ingredient in METHAMPHETAMINE HYDROCHLORIDE is methamphetamine hydrochloride. There is one drug master file entry for this compound. Three suppliers are listed for this compound. Additional details are available on the methamphetamine hydrochloride profile page.
Summary for 084931
| Tradename: | METHAMPHETAMINE HYDROCHLORIDE |
| Applicant: | Rexar |
| Ingredient: | methamphetamine hydrochloride |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 084931
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 5MG | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 10MG | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
